crystalline forms, saxagliptin chloridate, pharmaceutic composition, process for preparing the i-s form of chloridate and saxagliotin, process for preparing the ht form of saxagliptin chloridate use of crystalline sexagliptin and use of the iv s form of saxagloptine chloridate

摘要

The present invention relates to novel polymorphic forms of Saxagliptin Hydrochloride. The present invention also relates to methods of making polymorphic forms of Saxagliptin Hydrochloride.